| 0 |
GONIOTOMY |
1 |
0.2000 |
| 1 |
VITREOUS FIBRIN |
1 |
0.0357 |
| 2 |
CORNEAL THICKENING |
1 |
0.0147 |
| 3 |
REFRACTION DISORDER |
3 |
0.0103 |
| 4 |
IRIS NEOVASCULARISATION |
1 |
0.0080 |
| 5 |
ANTERIOR CHAMBER FIBRIN |
1 |
0.0078 |
| 6 |
INTRAOCULAR PRESSURE FLUCTUATION |
1 |
0.0051 |
| 7 |
INTERCEPTED PRODUCT PRESCRIBING ERROR |
6 |
0.0045 |
| 8 |
CORNEAL DEGENERATION |
1 |
0.0041 |
| 9 |
IRIS ADHESIONS |
2 |
0.0039 |
| 10 |
CORNEAL EROSION |
2 |
0.0037 |
| 11 |
CYSTOID MACULAR OEDEMA |
5 |
0.0027 |
| 12 |
VISUAL ACUITY TESTS ABNORMAL |
1 |
0.0018 |
| 13 |
OPHTHALMIC HERPES SIMPLEX |
1 |
0.0017 |
| 14 |
EYE LASER SURGERY |
1 |
0.0017 |
| 15 |
ANTERIOR CHAMBER INFLAMMATION |
1 |
0.0017 |
| 16 |
CORNEAL OPACITY |
2 |
0.0015 |
| 17 |
ANTERIOR CHAMBER CELL |
1 |
0.0014 |
| 18 |
DISINHIBITION |
2 |
0.0012 |
| 19 |
DETACHMENT OF RETINAL PIGMENT EPITHELIUM |
1 |
0.0011 |
| 20 |
PUNCTATE KERATITIS |
1 |
0.0011 |
| 21 |
MACULAR HOLE |
1 |
0.0007 |
| 22 |
CORNEAL ABRASION |
1 |
0.0007 |
| 23 |
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION |
1 |
0.0007 |
| 24 |
MACULAR OEDEMA |
4 |
0.0007 |
| 25 |
KERATOPATHY |
1 |
0.0006 |
| 26 |
SCLERITIS |
1 |
0.0006 |
| 27 |
CONTRAINDICATED PRODUCT PRESCRIBED |
1 |
0.0006 |
| 28 |
CORNEAL OEDEMA |
1 |
0.0004 |
| 29 |
INTRAOCULAR PRESSURE INCREASED |
5 |
0.0004 |
| 30 |
RETINAL VEIN OCCLUSION |
1 |
0.0003 |
| 31 |
CATARACT OPERATION |
2 |
0.0003 |
| 32 |
CATARACT |
20 |
0.0003 |
| 33 |
IRITIS |
1 |
0.0003 |
| 34 |
KERATITIS |
1 |
0.0003 |
| 35 |
IRIDOCYCLITIS |
1 |
0.0003 |
| 36 |
CONTRAINDICATED PRODUCT ADMINISTERED |
9 |
0.0003 |
| 37 |
UVEITIS |
4 |
0.0003 |
| 38 |
EUGLYCAEMIC DIABETIC KETOACIDOSIS |
1 |
0.0002 |
| 39 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 40 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 41 |
RETINAL DETACHMENT |
2 |
0.0002 |
| 42 |
GLAUCOMA |
4 |
0.0002 |
| 43 |
FOREIGN BODY SENSATION IN EYES |
1 |
0.0002 |
| 44 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 45 |
RETINAL HAEMORRHAGE |
1 |
0.0001 |
| 46 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 47 |
MANIA |
2 |
0.0001 |
| 48 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 49 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 50 |
EYE INFLAMMATION |
1 |
0.0001 |
| 51 |
ASPIRATION |
1 |
0.0001 |
| 52 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 53 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 54 |
OCULAR HYPERAEMIA |
3 |
0.0001 |
| 55 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 56 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 57 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 58 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 59 |
FEMUR FRACTURE |
1 |
0.0000 |
| 60 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 61 |
VISION BLURRED |
4 |
0.0000 |
| 62 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 63 |
PANIC ATTACK |
1 |
0.0000 |
| 64 |
EYE SWELLING |
1 |
0.0000 |
| 65 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 66 |
BLINDNESS |
1 |
0.0000 |
| 67 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 68 |
CELLULITIS |
1 |
0.0000 |
| 69 |
MEDICATION ERROR |
1 |
0.0000 |
| 70 |
EYE PAIN |
1 |
0.0000 |
| 71 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 72 |
DEPRESSION |
2 |
0.0000 |
| 73 |
HYPERHIDROSIS |
1 |
0.0000 |
| 74 |
COUGH |
2 |
0.0000 |
| 75 |
HOSPITALISATION |
1 |
0.0000 |
| 76 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 77 |
SOMNOLENCE |
1 |
0.0000 |
| 78 |
DECREASED APPETITE |
1 |
0.0000 |
| 79 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 80 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 81 |
PNEUMONIA |
1 |
0.0000 |
| 82 |
MALAISE |
1 |
0.0000 |
| 83 |
PAIN |
1 |
0.0000 |
| 84 |
OFF LABEL USE |
1 |
0.0000 |